Literature DB >> 3976814

Possible cardiovascular effects secondary to topical ophthalmic 2.5% phenylephrine.

F T Fraunfelder, S M Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3976814     DOI： 10.1016/0002-9394(85)90371-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  7 in total

1.  Dangers of ocular instillation of medications.

Authors:  A J Flach
Journal:  West J Med       Date:  1985-09

2.  Ocular phenylephrine 2.5% continues to be dangerous.

Authors:  Nauman Ahmed; Waleed Riad; Abdullah Altorpaq; Abdul Zahoor
Journal:  BMJ Case Rep       Date:  2009-03-02

Review 3.  Non-prescription sympathomimetic agents and hypertension.

Authors:  S S Chua; S I Benrimoj
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 4.  Systemic adverse effects of topical ophthalmic agents. Implications for older patients.

Authors:  J P Diamond
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

Review 5.  Systemic reactions to ophthalmic drug preparations.

Authors:  F T Fraunfelder; S M Meyer
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

6.  Pharmacologic interventions for mydriasis in cataract surgery.

Authors:  Mustafa Iftikhar; Samuel A Abariga; Barbara S Hawkins; Sidra Zafar; Tahreem A Mir; Henry Jampel; Fasika A Woreta
Journal:  Cochrane Database Syst Rev       Date:  2021-05-27

7.  Long Term and Intensive Use of Ophthalmic Topical Corticosteroids and the Risk of Positive Doping Test in Athletes: A Case Report.

Authors:  Tohid Seif Barghi; Farzad Kobarfard; Ahmad Hashemian; Jayran Zebardast
Journal:  Asian J Sports Med       Date:  2015-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.